. Author manuscript; available in PMC: 2017 Oct 24.

Published in final edited form as: Support Care Cancer. 2009 Jan 13;17(4):451–460. doi: 10.1007/s00520-008-0542-x

Table 5.

Reported toxicities during lidocaine and placebo use

Toxicity	Lidocaine	Placebo	P value
Dizziness
None	13 (93%)	14 (100%)	0.33
Moderate	1 (7%)	0 (0%)
Fatigue
None	13 (93%)	14 (100%)	0.33
Moderate	1 (7%)	0 (0%)
Hypersensitivity
None	14 (100%)	12 (86%)	0.15
Moderate	0 (0)%	2 (14%)
Neuromotor
None	13 (93%)	14 (100%)	0.33
Moderate	1 (7%)	0 (0%)
Pain–chest
None	14 (100%)	13 (93%)	0.33
Moderate	0 (0%)	1 (7%)
Rash–desquamation
None	11 (79%)	13 (93%)	0.24
Mild	2 (14%)	1 (7%)
Moderate	1 (7%)	0 (0%)
Worst toxicity
None	10 (71%)	10 (71%)	0.79
Mild	2 (14%)	3 (21%)
Moderate	2 (14%)	1 (7%)